IDiyas

For the Inventor, By the Inventor

The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Patent No.:

US 9687506 B1

PDFFull Text
Date of Patent:
Jun. 27, 2017

Filed:

Aug. 30, 2016

Sodium nitrite-containing pharmaceutical compositions

Applicant:

Hope Medical Enterprises, Inc., Scottsdale, AZ (US);

Inventors:

Craig Sherman, Scottsdale, AZ (US);

Anthony James Lepine, Greendale, WI (US);

Catherine Marie Smith, Grafton, WI (US);

Kevin Robert Wirtz, Belgium, WI (US);

Erich Schulze, Mission Viejo, CA (US);

Assignee:

Hope Medical Enterprises, Inc., Scottsdale, AZ (US);

Attorney:

Jones Day

Primary Examiner:

Robert T Crow

Assistant Examiner:

John P Nguyen

Int. Cl.
CPC ...
A61K 47/02 (2006.01); A61K 31/04 (2006.01); A61P 31/00 (2006.01); A61K 33/00 (2006.01); C01B 21/50 (2006.01); A61K 31/17 (2006.01); A61K 31/4418 (2006.01); A61K 31/4709 (2006.01); A61K 31/519 (2006.01); A61K 9/08 (2006.01); A61K 9/00 (2006.01);
U.S. Cl.
CPC ...
A61K 33/00 (2013.01); A61K 9/0019 (2013.01); A61K 9/08 (2013.01); A61K 31/17 (2013.01); A61K 31/4418 (2013.01); A61K 31/4709 (2013.01); A61K 31/519 (2013.01); C01B 21/50 (2013.01); Y10T 436/204998 (2015.01);
Abstract

Provided herein are pharmaceutically acceptable sodium nitrite and pharmaceutical compositions thereof. Also provided herein are methods for determining the total non-volatile organic carbon in a sodium nitrite-containing sample. Further provided herein are methods for producing pharmaceutically acceptable sodium nitrite. Still further provided herein are methods of treatment comprising the administration of pharmaceutically acceptable sodium nitrite.

Find Patent Forward Citations

Loading…